Novartis could expand direct-to-patient sales in US, CEO says
Go back to Novartis could expand direct-to-patient sales in US, CEO says| NOVARTIS AG (NYSE: NVS) | Delayed: 161.25 +9.19 (6.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.06 | 52 Week High | $89.15 | |||
| Open | $162.15 | 52 Week Low | $69.84 | |||
| Day High | $163.57 | P/E | N/A | |||
| Day Low | $160.21 | EPS | $0.00 | |||
| Volume | 4,334,669 | |||||
